Trials / Completed
CompletedNCT00750672
Follow-up Care After Treatment for Endometrial Cancer
Follow-up After Primary Therapy for Endometrial Cancer; Implementation of a Cancer Care Ontario Guideline: A Pilot Evaluation Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 20 (actual)
- Sponsor
- Ottawa Hospital Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purposes of this study are to examine the needs (symptoms, support, information) and satisfaction of women during follow-up in the community after completing treatment for endometrial cancer. This information will be collected from the perspective of the women themselves, their primary care providers (family physician or gynecologist) and the health care providers (oncologist, nurses, social worker, psychologist) at the cancer centre.
Detailed description
Research Question How has this transfer in follow-up care impacted performance indicators? * Volume of follow-up care transferred * Percentage of women, who have required a re-entry consultation * Fiscal implication of this transfer of follow-up care Patient stakeholders: * What are women's perceptions of the transition of follow-up care? * What are women's supportive care needs during the transition of follow-up care and ongoing needs? Primary Care Practitioner stakeholders: * What are the primary care practitioners' perceptions of the process of transition of follow-up care? * What are the primary care practitioners' educational needs? * What are the primary care practitioners' perceptions of the process of re-entry for in women with suspected recurrence? Tertiary Centre: Health care providers stakeholders o What are the perceptions of tertiary health care providers about the transition of follow-up care?
Conditions
Timeline
- Start date
- 2008-08-01
- Primary completion
- 2009-09-01
- Completion
- 2010-02-01
- First posted
- 2008-09-10
- Last updated
- 2012-07-13
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00750672. Inclusion in this directory is not an endorsement.